Full Press Release Details
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board
SAN DIEGO, CA / ACCESSWIRE / May 28, 2025 / Modular Medical,
Inc. (Nasdaq: MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared
patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, today announced
the appointment of Jeff Goldberg to its Board of Directors. Mr. Goldberg brings decades of experience in health care, life sciences, and
medical device leadership, including development of generic insulin. Mr. Goldberg began his work in medical technology alongside pioneering
medical entrepreneur, and founder of MiniMed, Alfred E. Mann.
"We are pleased to welcome Jeff Goldberg to the Modular Medical
board," said Jeb Besser, CEO of Modular Medical. "Jeff's unique background at the intersection of affordable drug-device
combinations will be instrumental, as we advance our mission to simplify insulin delivery and improve diabetes care worldwide."
Mr. Goldberg currently serves as Chairman of Lannett Company, Inc.,
a generic pharmaceutical manufacturer where he has helped execute a post-restructuring turnaround. During his tenure, Lannett has made
significant strides in launching a generic insulin product - progress that aligns closely with Modular Medical's commitment
to innovation and affordability in diabetes care.
In addition to his work at Lannett, Mr. Goldberg previously served
as President and CEO within Alfred E. Mann's incubator, IncuMed, where he oversaw multiple portfolio companies focused on drug-device
combination products, including an insulin patch-pump program. His tenure with Mr. Mann's enterprises included pivotal roles in
regulatory strategy, operations turnaround, and successful exits, underscoring his ability to guide early-stage technologies to commercial
"Modular Medical is advancing a truly disruptive approach to
insulin delivery," said Mr. Goldberg. "I'm excited to join the board and contribute to the Company's journey toward
simplifying treatment for people living with diabetes, particularly as the industry shifts toward more accessible and patient-friendly
Mr. Goldberg also serves on the boards of several healthcare and consumer-focused
companies, including ATI Physical Therapy, Cano Health, and Eating Recovery Centers. He holds a JD from UCLA School of Law and an AB from
About Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical
device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company
seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple
to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers"
and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device
professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and
invented and designed its insulin pump. More information is available at https://modular-medical.com.
Chief Executive Officer
Modular Medical, Inc.